Chizuko Watanabe Selected Research

Tamsulosin (Flomax)

2/2024

Characteristics of α1 -adrenoceptor antagonists-induced ejaculatory dysfunction on spontaneous seminal emission in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chizuko Watanabe Research Topics

Disease

20	Pain (Aches) 08/2022 - 03/2007
4	Neuralgia (Stump Neuralgia) 08/2022 - 01/2009
4	Hyperalgesia 01/2021 - 01/2014
3	Dementia (Dementias) 08/2022 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 03/2016
2	Ejaculatory Dysfunction 02/2024 - 02/2009
2	Hypersensitivity (Allergy) 01/2022 - 01/2021
2	Cystitis 01/2022 - 01/2021
2	Cancer Pain 01/2014 - 01/2009
1	Retrograde Ejaculation 02/2024
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 02/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2022
1	Overactive Urinary Bladder (Overactive Bladder) 01/2022
1	Pruritus (Itching) 03/2021
1	Phototoxic Dermatitis (Phototoxicity) 03/2021
1	Dystonia musculorum deformans type 1 01/2021
1	Dystonia (Limb Dystonia) 01/2021
1	Nociceptive Pain 01/2021
1	Glaucoma 01/2020
1	Cognitive Dysfunction 01/2019
1	Chronic Pain 01/2019
1	Myoclonus (Nocturnal Myoclonus) 01/2014
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2009
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2008
1	Ischemia 01/2008

Drug/Important Bio-Agent (IBA)

6	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 09/2007
5	Analgesics (Analgesic Drugs)IBA 08/2022 - 02/2012
5	Volatile Oils (Essential Oils)IBA 03/2021 - 09/2018
4	Opioid Receptors (Opioid Receptor)IBA 01/2020 - 02/2012
3	Gabapentin (Neurontin)FDA LinkGeneric 01/2021 - 01/2009
3	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 01/2009
3	Oxycodone (Oxycontin)FDA LinkGeneric 01/2020 - 01/2009
3	Fentanyl (Sublimaze)FDA LinkGeneric 01/2020 - 01/2009
3	Freund's AdjuvantIBA 01/2020 - 01/2014
2	Antipsychotic Agents (Antipsychotics)IBA 08/2022 - 03/2021
2	LipopolysaccharidesIBA 01/2022 - 01/2021
2	LigandsIBA 01/2021 - 01/2021
2	hemokinin-1IBA 03/2016 - 08/2010
2	Glutamic Acid (Glutamate)FDA Link 05/2012 - 01/2008
2	Opioid Analgesics (Opioids)IBA 02/2012 - 01/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2024
1	Tamsulosin (Flomax)FDA LinkGeneric 02/2024
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 01/2022
1	CytokinesIBA 01/2022
1	5-MethoxypsoralenIBA 03/2021
1	ATPases Associated with Diverse Cellular ActivitiesIBA 01/2021
1	Adenosine Triphosphatases (ATPase)IBA 01/2021
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2021
1	AntioxidantsIBA 01/2020
1	mesoglycanIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Narcotics (Narcotic Analgesics)IBA 02/2014
1	Ro 32-0432IBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 01/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012
1	Neurotransmitter Agents (Neurotransmitter)IBA 05/2012
1	Formaldehyde (Formol)FDA Link 05/2012
1	Capsaicin (Zostrix)FDA Link 05/2012
1	Insulin (Novolin)FDA Link 02/2009
1	Streptozocin (Streptozotocin)FDA Link 02/2009
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2009
1	Ketamine FDA LinkGeneric 01/2009
1	Retinaldehyde (Retinal)IBA 01/2008
1	N-Methylaspartate (NMDA)IBA 09/2007
1	substance P (1-7)IBA 09/2007
1	NociceptinIBA 03/2007

Therapy/Procedure

3	Aromatherapy 04/2020 - 09/2018
2	Intravesical Administration 01/2022 - 01/2021
2	Therapeutics 01/2019 - 01/2009
1	Off-Label Use 03/2021
1	Ligation 01/2021